Intracellular dynamics in rotavirus-like particles production: Evaluation of multigene and monocistronic infection strategies

Process Biochemistry

Volumn 41, Issue 10, 2006, Pages 2188-2199

  Roldão, António ^a   Vieira, Helena L A ^a   Alves, Paula M ^a   Oliveira, R ^b   Carrondo, Manuel J T ^a,b  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b Faculty of Pharmacy of the University of Porto   (Portugal)

Author keywords

Assembly; Model; mRNA; Protein; Rota VLP; vDNA

Indexed keywords

BIOCHEMISTRY; CARBON DIOXIDE; CELL CULTURE; DNA; GENETIC ENGINEERING; RNA; VIRUSES;

BACULOVIRUSES CODING; INTRACELLULAR DYNAMICS; MONOCISTRONIC INFECTION; MULTIGENES;

PROTEINS;

LEPIDOPTERA; ROTAVIRUS; SPODOPTERA FRUGIPERDA;

EID: 33748567742     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2006.06.019     Document Type: Article

References (48)

1. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., and Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9 5 (2003) 565-572
2. Fischer T.K., Bresee J.S., and Glass R.I. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22 Suppl 1 (2004) S49-S54
3. Parashar U.D., Holman R.C., Cummings K.C., Staggs N.W., Curns A.T., Zimmerman C.M., et al. Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics 106 6 (2000) 1413-1421
4. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344 8 (2001) 564-572
5. Bernstein D.I., Sack D.A., Rothstein E., Reisinger K., Smith V.E., O'Sullivan D., et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet 354 9175 (1999) 287-290
6. Clements-Mann M.L., Dudas R., Hoshino Y., Nehring P., Sperber E., Wagner M., et al. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine 19 32 (2001) 4676-4684
7. Bernstein D.I., Sack D.A., Reisinger K., Rothstein E., and Ward R.L. Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants. J Infect Dis 186 10 (2002) 1487-1489
8. Haber P., Chen R.T., Zanardi L.R., Mootrey G.T., English R., and Braun M.M. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?. Pediatrics 113 4 (2004) e353-e359
9. Crawford S.E., Estes M.K., Ciarlet M., Barone C., O'Neal C.M., Cohen J., et al. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J Virol 73 6 (1999) 4813-4822
10. Noad R., and Roy P. Virus-like particles as immunogens. Trends Microbiol 11 9 (2003) 438-444
11. Coste A., Sirard J.C., Johansen K., Cohen J., and Kraehenbuhl J.P. Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea. J Virol 74 19 (2000) 8966-8971
12. Fromantin C., Jamot B., Cohen J., Piroth L., Pothier P., and Kohli E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. J Virol 75 22 (2001) 11010-11016
13. O'Neal C.M., Crawford S.E., Estes M.K., and Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 71 11 (1997) 8707-8717
14. Madore H.P., Estes M.K., Zarley C.D., Hu B., Parsons S., Digravio D., et al. Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine. Vaccine 17 19 (1999) 2461-2471
15. Palomares L.A., Lopez S., and Ramirez O.T. Strategies for manipulating the relative concentration of recombinant rotavirus structural proteins during simultaneous production by insect cells. Biotechnol Bioeng 78 6 (2002) 635
16. Labbe M., Charpilienne A., Crawford S.E., Estes M.K., and Cohen J. Expression of rotavirus VP2 produces empty corelike particles. J Virol 65 6 (1991) 2946-2952
17. Prasad B.V., Wang G.J., Clerx J.P., and Chiu W. Three-dimensional structure of rotavirus. J Mol Biol 199 2 (1988) 269-275
18. Vieira H.L., Estevao C., Roldao A., Peixoto C.C., Sousa M.F., Cruz P.E., et al. Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production. J Biotechnol 120 1 (2005) 72-82
19. Kim Y., Nielsen P.R., Hodgins D., Chang K.O., and Saif L.J. Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. Vaccine 20 7/8 (2002) 1248-1258
20. Blutt S.E., Warfield K.L., O'Neal C.M., Estes M.K., and Conner M.E. Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine 24 8 (2005) 1170-1179
21. Bertolotti-Ciarlet A., Ciarlet M., Crawford S.E., Conner M.E., and Estes M.K. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 21 25/26 (2003) 3885-3900
22. Mena J.A., Ramirez O.T., and Palomares L.A. Quantification of rotavirus-like particles by gel permeation chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 824 1/2 (2005) 267-276
23. Mena J.A., Ramirez O.T., and Palomares L.A. Intracellular distribution of rotavirus structural proteins and virus-like particles expressed in the insect cell-baculovirus system. J Biotechnol 122 4 (2006) 443-452
24. Pattenden L.K., Middelberg A.P., Niebert M., and Lipin D.I. Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol 23 10 (2005) 523-529
25. Cruz P.E., Cunha A., Peixoto C.C., Clemente J., Moreira J.L., and Carrondo M.J. Optimization of the production of virus-like particles in insect cells. Biotechnol Bioeng 60 4 (1998) 408-418
26. Jiang B., Estes M.K., Barone C., Barniak V., O'Neal C.M., Ottaiano A., et al. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine 17 7/8 (1999) 1005-1013
27. Maranga L., Brazão T.F., and Carrondo M.J.T. Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. Biotechnol Bioeng 84 2 (2003) 245-253
28. Tosser G., Labbe M., Bremont M., and Cohen J. Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses. J Virol 66 10 (1992) 5825-5831
29. Petricevich V.L., Palomares L.A., Gonzalez M., and Ramirez O.T. Parameters that determine virus adsorption kinetics: toward the design of better infection strategies for the insect cell-baculovirus expression system. Enzyme Microb Technol 29 1 (2001) 52-61
30. Mena J., Ramirez O.T., and Palomares L. Titration of non-occluded baculovirus using a cell viability assay. Biotechniques 34 2 (2003) 260-264
31. Dee K.U., and Shuler M.L. A mathematical model of the trafficking of acid-dependent enveloped viruses: application to the binding, uptake, and nuclear accumulation of baculovirus. Biotechnol Bioeng 54 5 (1997) 468-490
32. Power J., Greenfield P.F., Nielsen L., and Reid S. Modelling the growth and protein production by insect cells following infection by a recombinant baculovirus in suspension culture. Cytotechnology 9 1-3 (1992) 149-155
33. Power J.F., Reid S., Radford K.M., Greenfield P.F., and Nielsen L.K. Modeling and optimization of the baculovirus expression vector system in batch suspension culture. Biotechnol Bioeng 44 6 (1994) 710-719
34. Rosinski M., Reid S., and Nielsen L.K. Kinetics of baculovirus replication and release using real-time quantitative polymerase chain reaction. Biotechnol Bioeng 77 4 (2002) 476-480
35. Lodish H., Baltimore D., and Darnell J. Molecular cell biology (1986), Scientific American Books, Inc., New York, USA
36. Dalal N.G., and Bentley W.E. Mathematical characterization of insect cell (Sf-9) death in suspended culture. Biotechnol Lett 21 (1999) 325-329
37. Hu Y.-C., and Bentley W.E. A kinetic and statistical-thermodynamic model for baculovirus infection and virus-like particle assembly in suspended insect cells. Chem Eng Sci 55 (2000) 3991-4008
38. Hu Y.C., and Bentley W.E. Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: deterministic predictions and experimental results. Biotechniques 75 1 (2001) 104-119
39. Battle T., Losberger C., and Glez L. Optimisation of virus stock production and cell infection conditions for protein expression. Bioprocessing (2004) 27-32
40. De Gooijer C.D., Koken R.H.M., Van Lier F.L.J., Kool M., Vlak J.M., and Tramper J. A structured dynamic model for the baculovirus infection process in insect-cell reactor configurations. Biotechnol Bioeng 40 4 (1992) 537-548
41. Wu S.C., Jarvis D.L., Dale B.E., and Liao J.C. Heterologous protein expression affects the death kinetics of baculovirus-infected insect cell cultures: a quantitative study by use of n-target theory. Biotechnol Prog 10 1 (1994) 55-59
42. Wu S.-C., Dale B.E., and Liao J.C. Kinetic characterization of baculovirus-induced cell death in insect cell cultures. Biotechnol Bioeng 41 1 (1993) 104-110
43. Jang J.D., Sanderson C.S., Chan L.C.L., Barford J.P., and Reid S. Structured modeling of recombinant protein production in batch and fed-batch culture of baculovirus-infected insect cells. Cytotechnology 34 (2000) 71-82
44. Licari P., and Bailey J.E. Modeling the population dynamics of baculovirus-infected insect cells: optimizing infection strategies for enhanced recombinant protein yields. Biotechnol Bioeng 39 4 (1992) 432-441
45. Radford K.M., Cavegn C., Bertrand M., Bernard A.R., Reid S., and Greenfield P.F. The indirect effects of multiplicity of infection on baculovirus expressed proteins in insect cells: secreted and non-secreted products. Cytotechnology 24 9 (1997) 73-81
46. Volkman L.E., and Goldsmith P.A. Mechanism of neutralization of budded Autographa californica nuclear polyhedrosis virus by a monoclonal antibody: inhibition of entry by adsorptive endocytosis. Virology 143 (1985) 185-195
47. Blissard G.W., and Rohrmann G.F. Baculovirus diversity and molecular biology. Annu Rev Entomol 35 (1990) 127-155
48. Palomares L.A., Estrada-Mondaca S., and Ramirez O.T. Production of recombinant proteins: challenges and solutions. Methods Mol Biol 267 (2004) 15-52